Hostname: page-component-586b7cd67f-2plfb Total loading time: 0 Render date: 2024-11-29T12:08:13.488Z Has data issue: false hasContentIssue false
  • English
  • Français

Assessment and management of delirium: A focus on hepatic encephalopathy

Published online by Cambridge University Press:  08 October 2012

Candace C. Coggins  and
Carol P. Curtiss
Candace C. Coggins*
Affiliation:
Hospice Care of the Low Country, Bluffton, South Carolina
Carol P. Curtiss
Affiliation:
Curtiss Consulting, Greenfield, Massachusetts Tufts University School of Medicine, Boston, Massachusetts
*
Address correspondence and reprint requests to: Candace C. Coggins, Hospice Care of the Low Country, 119 Palmetto Way, Bluffton, South Carolina 29927. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

This purpose of this article is to promote comprehensive assessment, differential evaluation and provision of care which optimizes benefit while minimizing burden. Delirium is a debilitating neuropsychiatric complication that is highly prevalent in palliative care. It is multifactorial and may be related to infection, disease progression, metabolic state or medication toxicity. There are three proposed sub-types of delirium with the hypoactive/ hypoalert variant being most often underdiagnosed and undertreated. The inadequate management of all types of delirium is associated with increased personal and family distress, lengthier hospital stays, and escalating healthcare costs. This article reviews the assessment, diagnosis and treatment for delirium in general and hepatic encephalopathy in particular. A number of valid and reliable tools are discussed, as they assist in screening, symptom appraisal, diagnosis, and treatment planning. It is recognized that nurses are particularly well positioned to make bedside observations, to document changes over time, and to educate and support patients and their families. Searching for the etiology of delirium, developing individualized plans of care consistent with patient goals, and endorsing the benefit of consultation/referral are discussed as key roles for palliative care providers from all disciplines. New and novel therapies in the management of hepatic encephalopathy are discussed, as they expand treatment options for patients at all points along the trajectory of liver disease.

Keywords

DeliriumHepatic encephalopathyPalliative careAssessment of deliriumManagement of delirium
Type
Review Article
Information
Palliative & Supportive Care , Volume 11 , Issue 4 , August 2013 , pp. 341 - 352
Copyright
Copyright © Cambridge University Press 2012 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th Ed., Text Revision. Arlington, VA: American Psychiatric Association.Google Scholar
American Pain Society (2003). Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain, 5th ed.Glenview: IL: American Pain Society.Google Scholar
Adamis, D., Sharma, N., Whelan, P.J.P., et al. (2010). Delirium scales: A review of current evidence. Aging & Mental Health, 14, 543–555.Google Scholar
Agar, M., Currow, D.C., Plummer, J., et al. (2008). Differing management of people with advanced cancer and delirium by four subspecialties. Palliative Medicine, 22, 633–640.Google Scholar
Alici-Evcimen, Y. & Breitbart, W. (2008). An update on the use of antipsychotics in the treatment of delirium. Palliative and Supportive Care, 6, 177–182.Google Scholar
Bajaj, J.S. (2010). Review article: The modern management of hepatic encephalopathy. Alimentary Pharmacology & Therapeutics, 31, 537–547.CrossRefGoogle ScholarPubMed
Bajaj, J.S., Saeian, K., Schubert, C.M., et al. (2009). Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test. Hepatology, 50, 1175–1183.Google Scholar
Barnes, J., Kite, S. & Kumar, M. (2010). The recognition and documentation of delirium in hospital palliative care inpatients. Palliative and Supportive Care, 8, 133–136.Google Scholar
Bass, N.M., Mullen, K.D., Sanyal, A., et al. (2010). Rifaximin treatment in hepatic encephalopathy. The New England Journal of Medicine, 362, 1071–1081.Google Scholar
Blei, A.T. & Cordoba, J. (2001). The practice parameters committee of the American college of gastroenterology. Practice guidelines: Hepatic encephalopathy. The American Journal of Gastroenterology, 96, 1968–1976.Google Scholar
Boettger, S. & Breitbart, W. (2005). Atypical antipsychotics in the management of delirium: A review of the empirical literature. Palliative and Supportive Care, 3, 227–238.Google Scholar
Boettger, S., Passik, S. & Breitbart, W. (2009). Delirium superimposed on dementia versus delirium in the absence of dementia: Phenomenological differences. Palliative and Supportive Care, 7, 495–450.Google Scholar
Bond, S.M. & Neelon, V. (2008). Delirium resolution in hospitalized older patients with cancer. Cancer Nursing, 31, 444–451.Google Scholar
Breitbart, W., Gibson, C. & Tremblay, A. (2002). The delirium experience: Delirium recall and delirium[related distress in hospitalized patients with cancer, their spouses/caregivers, and their nurses. Psychosomatics, 43, 183–194.Google Scholar
Breitbart, W., Marotta, R., Platt, M.M., et al. (1996). Double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDs patients. American Journal of Psychiatry, 153, 231–237.Google ScholarPubMed
Breitbart, W. & Alici, Y. (2008). Agitation and delirium at the end of life. “We couldn't manage him.” Journal of the American Medical Association, 300, 2898–2910.Google Scholar
Casarett, D.J. & Inouye, S.K. (2001). Diagnosis and management of delirium near the end of life. Annals of Internal Medicine, 135, 32–40.Google Scholar
Cash, W.J., McConville, P., McDermott, E., et al. (2010). Current concepts in the assessment and treatment of hepatic encephalopathy. QJM, 103, 9–16.Google Scholar
Centeno, C., Sanz, A. & Bruera, E. (2004). Delirium in advanced cancer patients. Palliative Medicine, 18, 184–194.Google Scholar
Cordoba, J. & Minguez, B. (2008). Hepatic encephalopathy. Seminars in Liver Disease, 28, 70–80.Google Scholar
Ferenci, P. (2010). Hepatitis: Treatment of chronic hepatitis C: How much interferon is enough? Nature Reviews Gastroenterology & Hepatology, 7, 191.Google Scholar
Ferenci, P., Lockwood, A., Mullen, K.D., et al. (2002). Hepatic encephalopathy—definition, nomenclature, diagnosis, and quantification: Final report of the Working Party at the 11th World Congresses of Gastroenterology, Vienna. Hepatology, 2, 716–721.Google Scholar
Fine, P.G. & Portenoy, R.K. (2007). A Clinical Guide to Opioid Analgesia, 2nd ed. New York: Vendome Group.Google Scholar
Fine, P.G., Portenoy, R.K. & Ad Hoc Expert Panel on Evidence Review and Guidelines for Opioid Rotation. (2009). Establishing “Best practices” for opioid rotation: Conclusions of an expert panel. Journal of Pain and Symptom Management, 38, 418–425.Google Scholar
Fleishman, S.B., Lesko, L.M. & Breitbart, W. (1993). Treatment of organic mental disorders in cancer patients. In Psychiatric Aspects of Symptom Management in Cancer Patients, Breitbart, W., Holland, J.C. (eds). Washington, DC: American Psychiatric Press, Inc.Google Scholar
Foster, K.J., Lin, S. & Turck, C. (2010). Current and emerging strategies for treating hepatic encephalopathy. Critical Care Nursing Clinics of North America, 22, 341–350.Google Scholar
Harris, D. (2007). Delirium in advanced disease. Postgraduate Medicine, 83, 525–528.Google Scholar
Hassanein, T., Blei, A.T., Hilsabeck, R., et al. (2009). Performance of the hepatic encephalopathy scoring algorithm in a clinical trial of patients with cirrhosis and severe hepatic encephalopathy. American Journal of Gastroenterology, 104, 1392–1400.Google Scholar
Irwin, S.A., Rao, S., Bower, K.A., et al. (2008). Psychiatric issues in palliative care: Recognition of delirium in patients enrolled in hospice care. Palliative and Supportive Care, 6, 159–164.Google Scholar
Jackson, K. & Lipman, A.G. (2004). Drug therapy for delirium in terminally ill patients. Cochrane Database of Systematic Reviews, 2, CD004770.Google Scholar
Kuebler, K.K., Heidrich, D.E., Vena, C., et al. (2006). Delirium, confusion, and agitation. In Textbook of Palliative Nursing, 2nd ed., Ferrell, B.R., Coyle, N. (eds.). pp. 401–442. New York: Oxford University Press.Google Scholar
Leonard, M., Agar, M., Mason, C., et al. (2008). Delirium issues in palliative care settings. Journal of Psychosomatic Research, 65, 289–298.CrossRefGoogle ScholarPubMed
Mullen, K.D., Ferenci, P., Bass, N.M., et al. (2007). An algorithm for the management of hepatic encephalopathy. Seminars in Liver Disease, 27, 32–47.Google Scholar
Mullen, K.D. & Prakash, R. (2010). Rifaximin for the treatment of hepatic encephalopathy. Expert review. Gastroenterology and Hepatology, 4, 665–677.Google Scholar
Namba, M., Morita, T., Imura, C., et al. (2007). Terminal delirium: Families' eperience. Palliative Medicine, 21, 587–594.Google Scholar
Ody, P. (1993). The Complete Medicinal Herbal. London: Dorling Kindersley Limited.Google Scholar
Ortiz, M., Cordoba, J., Doval, E., et al. (2007). Development of a clinical hepatic encephalopathy staging scale. Alimentary Pharmacology & Therapeutics, 26, 859–867.Google Scholar
Pasero, C. & McCaffery, M. (2011). Pain Assessment and Pharmacologic Management. St. Louis: Elsevier.Google Scholar
Phongsamran, P.V., Kim, J.W., Abbott, J.C., et al. (2010). Pharmacotherapy for hepatic encephalopathy. Drugs, 70, 1131–1148.Google Scholar
Plauth, M., Cabre, E., Riggio, O., et al. (2006). ESPEN Guidelines on enteral nutrition: Liver disease. Clinical Nutrition, 25, 285–294.Google Scholar
Portenoy, R.K. & Bruera, E. (1997). Topics in Palliative Care. New York: Oxford University Press.Google Scholar
Prakash, R. & Mullen, K.D. (2010). Mechanism, diagnosis and management of hepatic encephalopathy. Gastroenterology and Hepatology, 7, 515–525.Google Scholar
Riordan, S.M. & Williams, R.. (2010). Gut flora and hepatic encephalopathy in patients with cirrhosis. New England Journal of Medicine, 362, 1140–1142.Google Scholar
Ryan, K., Leonard, M., Guerin, S., et al. (2009). Validation of the confusion assessment method in the palliative care setting. Palliative Medicine, 23, 40–45s.Google Scholar
Schreier, A.M. (2010). Nursing care, delirium and pain management for the hospitalized older adult. Pain Management Nursing, 11, 177–185.Google Scholar
Schultz, V., Hänsel, R. & Tyler, V.E. (1998). Rational Phytotherapy: A Physicians' Guide to Herbal Medicine. Berlin: Springer–Verlag.Google Scholar
Schuurmans, M.J., Deschamps, P.I., Markham, S.W., et al. (2003a). The measurement of delirium: Review of scales. Research and Theory for Nursing Practice, 17, 207–224.Google Scholar
Schuurmans, M.J., Shortridge-Baggett, L.M. & Duursma S.A. (2003b). The delirium observation screening scale: A screening instrument for delirium. Research and Theory for Nursing Practice, 17, 31–50.CrossRefGoogle Scholar
Siddiqi, N., House, A.O. & Holmes, J.D. (2006). Occurrence and outcome of delirium in medical in-patients: a systematic literature review. Age and Ageing, 35, 350–364.Google Scholar
Stagno, D., Gibson, C. & Breitbart, W. (2004). The delirium subtypes: A review of prevalence, phenomeology, pathophysiology, and treatment response. Palliative & Supportive Care, 2, 171–179.Google Scholar
Sundaram, V. & Shaikh, O.S. (2009). Hepatic encephalopathy: Pathophysioogy and emerging therapies. Medical Clinics of North America, 93, 819–336.Google Scholar
Vella-Brincat, J. & Macleod, A.D. (2004). Haloperidol in palliative care. Palliative Medicine, 18, 195–201.Google Scholar
Wei, L.A., Fearing, M.A. & Inouye, S.K. (2008). The Confusion Assessment Method: a systematic review of current usage. Journal of the American Geriatric Society, 56, 823–830.Google Scholar
Wolf, D.C. (2011). eMedicine. Hepatic Encephalopathy http://emedicine.medscape.com/article/186101-print.Google Scholar
Wright, G. & Jalan, R. (2007). Management of hepatic encephalopathy in patients with cirrhosis. Best Practice & Research in Clinical Gastroenterology, 21, 95–110.Google Scholar